Clinical trial
Pioglitazone Therapy Targeting Fatigue in Breast Cancer
NCT05013255 is registered in ClinicalTrials.gov with West Virginia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pioglitazone Therapy Targeting Fatigue in Breast Cancer
- Lead sponsor
- West Virginia University
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- December 23, 2021
- Completion date
- December 31, 2026
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, muscle fatigue